The Dangers of Excluding Women From HIV Prevention Drug Tests
Women were well-represented in studies of Truvada for PrEP. (The drug had been in use since 2004 as a form of treatment for people who already have HIV infections.) With between 20 and 52 percent cisgender women, the successful PrEP trials were strong enough to establish its effectiveness and enable its broad approval. And in […]
The Dangers of Excluding Women From HIV Prevention Drug Tests Read More ยป